ES2081763A1 - Forma puridicada de estreptograminas, su preparacion y las composiciones farmaceuticas que la contienen. - Google Patents

Forma puridicada de estreptograminas, su preparacion y las composiciones farmaceuticas que la contienen.

Info

Publication number
ES2081763A1
ES2081763A1 ES09400294A ES9400294A ES2081763A1 ES 2081763 A1 ES2081763 A1 ES 2081763A1 ES 09400294 A ES09400294 A ES 09400294A ES 9400294 A ES9400294 A ES 9400294A ES 2081763 A1 ES2081763 A1 ES 2081763A1
Authority
ES
Spain
Prior art keywords
radical
image
purified form
streptogramines
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09400294A
Other languages
English (en)
Other versions
ES2081763B1 (es
Inventor
Pascal Anger
Bertrand Bannavaud
Alain Callet
Patrick Lefevre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Priority claimed from APAP/P/1994/000660A external-priority patent/AP520A/en
Priority claimed from CN94195158A external-priority patent/CN1159197A/zh
Publication of ES2081763A1 publication Critical patent/ES2081763A1/es
Application granted granted Critical
Publication of ES2081763B1 publication Critical patent/ES2081763B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06182—Dipeptides with the first amino acid being heterocyclic and Pristinamycin II; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

FORMA PURIFICADA DE ESTREPTOGRAMINAS, SU PREPARACION Y LAS COMPOSICIONES FARMACEUTICAS QUE LA CONTIENEN, CUYA FORMA PURIFICADA ESTA CONSTITUIDA POR UNA ASOCIACION DE UNO O VARIOS COMPONENTES DEL GRUPO B DE LAS ESTREPTOGRAMINAS, DE FORMULA GENERAL I, EN LA QUE A1 TIENE EL SIGNIFICADO DADO EN LA DESCRIPCION Y UNO O VARIOS COMPONENTES MINORITARIOS DEL GRUPO A DE LAS ESTREPTOGRAMINAS, DE FORMULA GENERAL II, EN LA QUE R''" ES H O UN RADICAL METILO O ETILO, EN ESTADO DE COCRISTALIZADO, DE COPRECIPITADO O DE MEZCLA FISICA DE LOS POLVOS.
ES09400294A 1993-02-17 1994-02-16 Forma puridicada de estreptograminas, su preparacion y las composiciones farmaceuticas que la contienen. Expired - Fee Related ES2081763B1 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR9301787A FR2701709B1 (fr) 1993-02-17 1993-02-17 Forme purifiée de streptograminés, sa préparation et les compositions pharmaceutiques qui la contiennent.
APAP/P/1994/000660A AP520A (en) 1993-02-17 1994-08-01 Purified form of streptogramins, its preparation and pharmaceutical compositions containing it.
CN94195158A CN1159197A (zh) 1993-02-17 1994-08-12 链阳菌素的纯化形式、其制备和含有它的药物组合物
PCT/FR1994/001006 WO1996005219A1 (fr) 1993-02-17 1994-08-12 Forme purifiee de streptogramines, sa preparation et les compositions pharmaceutiques qui la contiennent
OA60964A OA10400A (fr) 1993-02-17 1997-02-07 Forme purifiée de streptogramines sa préparation et les compositions pharmaceutiques qui la contiennent

Publications (2)

Publication Number Publication Date
ES2081763A1 true ES2081763A1 (es) 1996-03-01
ES2081763B1 ES2081763B1 (es) 1997-01-16

Family

ID=33437085

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09400294A Expired - Fee Related ES2081763B1 (es) 1993-02-17 1994-02-16 Forma puridicada de estreptograminas, su preparacion y las composiciones farmaceuticas que la contienen.

Country Status (21)

Country Link
JP (1) JPH06298664A (es)
AU (1) AU678785B2 (es)
BE (1) BE1006554A3 (es)
BR (1) BR9408613A (es)
CA (1) CA2115807A1 (es)
CZ (1) CZ285541B6 (es)
ES (1) ES2081763B1 (es)
FI (1) FI111009B (es)
FR (1) FR2701709B1 (es)
GB (1) GB2275269B (es)
GR (1) GR1002385B (es)
HU (1) HUT66821A (es)
IL (1) IL108641A (es)
IT (1) IT1269214B (es)
LU (1) LU88454A1 (es)
NO (1) NO940533D0 (es)
NZ (1) NZ250884A (es)
PL (1) PL174835B1 (es)
PT (1) PT101460B (es)
SK (1) SK18494A3 (es)
ZA (1) ZA941024B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2723373B1 (fr) 1994-08-02 1996-09-13 Rhone Poulenc Rorer Sa Forme purifiee de streptogramines, sa preparation et les compositions pharmaceutiques qui la contiennent
FR2841563B1 (fr) * 2002-06-28 2006-09-01 Aventis Pharma Sa Nouveaux variants du polypeptide papm de bacteries du genre streptomyces
ITUB20169994A1 (it) * 2016-01-14 2017-07-14 Phf Sa Nuove forme cristalline di farmaci immunomodulatori

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8504202A1 (es) * 1983-07-13 1985-04-01 Rhone Poulenc Sante Procedimiento para la obtencion de nuevos derivados de sinergistinas
FR2619008A1 (fr) * 1987-08-03 1989-02-10 Cird Utilisation de synergistines dans des compositions pharmaceutiques ou cosmetiques anti-acneiques
WO1992017491A1 (fr) * 1991-03-28 1992-10-15 Rhone-Poulenc Rorer S.A. Procede de preparation enzymatique de macrolactone
WO1993020182A1 (fr) * 1992-04-01 1993-10-14 Rhone-Poulenc Rorer S.A. Microorganismes, procede de preparation et utilisation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8504202A1 (es) * 1983-07-13 1985-04-01 Rhone Poulenc Sante Procedimiento para la obtencion de nuevos derivados de sinergistinas
FR2619008A1 (fr) * 1987-08-03 1989-02-10 Cird Utilisation de synergistines dans des compositions pharmaceutiques ou cosmetiques anti-acneiques
WO1992017491A1 (fr) * 1991-03-28 1992-10-15 Rhone-Poulenc Rorer S.A. Procede de preparation enzymatique de macrolactone
WO1993020182A1 (fr) * 1992-04-01 1993-10-14 Rhone-Poulenc Rorer S.A. Microorganismes, procede de preparation et utilisation

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHEM. ABS. Vol. 110, n‘ 7, 13 Febrero 1989 (Columbus, Ohio, U.S.A.), pßgina 551, columna R, resumen n‘ 56082K, SHARM et al., "Isolation of factor A (Virginiamycin M1) and factor B (mixture of VS1 and VS4) from a commercial feed additive formulation", Bull. Soc. Chim. Belg. 1988, 97(3), 185-192 (Eng). * Resumen * *
J. FREUD'HOMME et al. Pristinamycine isolement, caracterisation et identification des constituants. Bulletin de la Societe chimique de France. 1968, Vol. 2, pßginas 585-591. *

Also Published As

Publication number Publication date
AU678785B2 (en) 1997-06-12
JPH06298664A (ja) 1994-10-25
GB9403057D0 (en) 1994-04-06
IL108641A0 (en) 1994-05-30
GB2275269B (en) 1997-07-09
FI111009B (fi) 2003-05-15
ES2081763B1 (es) 1997-01-16
FI940717A0 (fi) 1994-02-16
ITMI940192A0 (it) 1994-02-03
IL108641A (en) 1998-12-27
BR9408613A (pt) 1997-09-16
IT1269214B (it) 1997-03-21
HUT66821A (en) 1995-01-30
HU9400447D0 (en) 1994-05-30
SK18494A3 (en) 1995-02-08
LU88454A1 (fr) 1994-12-01
GR1002385B (el) 1996-07-03
CZ32694A3 (en) 1994-09-14
AU5510094A (en) 1994-08-25
FI940717A (fi) 1994-08-18
NZ250884A (en) 1995-12-21
CA2115807A1 (fr) 1994-08-18
ZA941024B (en) 1994-08-25
GB2275269A (en) 1994-08-24
GR940100078A (el) 1994-10-31
FR2701709B1 (fr) 1995-04-07
FR2701709A1 (fr) 1994-08-26
CZ285541B6 (cs) 1999-09-15
NO940533D0 (no) 1994-02-16
PL174835B1 (pl) 1998-09-30
NO940533L (es) 1994-08-18
PT101460B (pt) 1999-11-30
PL302250A1 (en) 1994-08-22
BE1006554A3 (fr) 1994-10-11
PT101460A (pt) 1994-09-30
ITMI940192A1 (it) 1995-08-03

Similar Documents

Publication Publication Date Title
NZ244021A (en) Benzylthiazolidinedione derivatives, preparation and pharmaceutical compositions thereof
ZA983618B (en) Novel cyclosporin derivatives their preparation and the pharmaceutical compositions which contain them
ZA948670B (en) New benzoyl guanidine derivatives,the preparation thereof and their use in pharmaceutical compositions
AU673893B2 (en) New pyridothiadiazones, processes for their preparation and the pharmaceutical compositions which contain them
AU8729791A (en) Pharmaceutical formulations
CA2065285A1 (en) Antimalarial compositions
DE69317877D1 (en) 4''-deoxyerythromycinderivate
NZ244320A (en) Acylals of imidazole-5-carboxylic acid, preparation and pharmaceutical compositions thereof
ZA93494B (en) Napthalene amides and sulphonamides, processes for their preparation and pharmaceutical compositions containing them
IL110460A0 (en) Bis-naphthalimides and pharmaceutical compositions containing them
TW334434B (en) Novel quinazoline compound and anti-tumor agent
ES2081763A1 (es) Forma puridicada de estreptograminas, su preparacion y las composiciones farmaceuticas que la contienen.
TW252979B (es)
SG81198A1 (en) Purified form of streptogramins, its preparation and pharmaceutical compositions containing it
ZA934389B (en) Peptide compounds having bradykinin-antagonist activity, process for their preparation and the pharmaceutical compositions which contain them
ZA942964B (en) Pyrrolopyrazine compounds processes for their preparation and the pharmaceutical compositions which contain them
GR3023941T3 (en) Cyclic derivatives of angiopeptin, their preparation and their pharmaceutical compositions.
TW234718B (es)
IL104444A0 (en) Alpha-aryl-alpha-hydroxy-beta-imidazolinyl-propionamides,their preparation and pharmaceutical compositions containing them
AU653968B2 (en) Use of phenylethanolaminotetralins for the preparation of anti-depressant and anti-stress pharmaceutical compositions
WO1995019777A3 (fr) Utilisation de diesters de muramyl peptides, dans une forme orale, comme immunostimulants
AP9400660A0 (en) Purified form of streptogramins, its preparation and pharmaceutical compositions containing it
TNSN94076A1 (fr) Forme purifiee de streptogramines, sa preparation et les compositions pharmaceutiques qui la contiennent
CA2188508A1 (en) Gonadotropins with non-native disulfide bridges
IT1262990B (it) Derivati peptidici, loro preparazione e loro impiego come medicamenti,in particolare antagonisti dell'lh-rh

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19940216

Kind code of ref document: B1

Effective date: 19940216

EC2A Search report published

Date of ref document: 19980516

Kind code of ref document: A1

Effective date: 19980516

FC2A Grant refused

Effective date: 19990607

PC2A Transfer of patent
FD2A Announcement of lapse in spain

Effective date: 20180806